Biological preparations for the treatment of cancer using polypeptides and genetically engineered cells; pharmaceutical preparations for targeting tissues based on select tissue markers and ligands; pharmaceutical preparations for the purpose of binding ligands using engineered polypeptides and receptors; pharmaceutical preparations for immunotherapy using polypeptides and genetically engineered cells; pharmaceutical preparations for immune cell therapy using polypeptides and genetically engineered cells

'base':19 'bind':32 'biolog':1 'cancer':7 'cell':13,48,53,60 'engin':12,35,47,59 'genet':11,46,58 'immun':52 'immunotherapi':42 'ligand':25,33 'marker':23 'pharmaceut':14,26,39,49 'polypeptid':9,36,44,56 'prepar':2,15,27,40,50 'purpos':30 'receptor':38 'select':21 'target':17 'therapi':54 'tissu':18,22 'treatment':5 'use':8,34,43,55

SPARX

Owners

Goods & Services